Literature DB >> 12375178

The role of T-lymphocytes in hypercholesterolemia-induced leukocyte-endothelial interactions.

Karen Y Stokes1, E Chris Clanton, Kimberly S Bowles, John W Fuseler, Deborah Chervenak, Robert Chervenak, Stephen R Jennings, D Neil Granger.   

Abstract

OBJECTIVE: Hypercholesterolemia promotes the adhesion of leukocytes to vascular endothelium in large and microscopic blood vessels. Lymphocytes that can modulate endothelial cell adhesion molecule expression have been implicated in the altered structure and function of large arterial vessels associated with chronic hypercholesterolemia. This study assesses the contribution of CD4(+) and CD8(+) T-cells to acute inflammatory responses observed in the microcirculation of hypercholesterolemic mice.
METHODS: Intravital microscopy was used to quantify baseline leukocyte-endothelial cell interactions in cremasteric postcapillary venules of wild-type (WT) and severe combined immunodeficient (SCID) mice placed on a normal (ND) or high-cholesterol (HC) diet for 2 weeks. A group of SCID-HC mice received splenocytes from WT-HC mice (WT-->SCID). Separate WT-HC groups were depleted of neutrophils or CD4(+) and/or CD8(+) T-cells.
RESULTS: WT-HC mice, compared with WT-ND, exhibited exaggerated leukocyte adherence and emigration. These leukocytes were predominantly granulocytes. These responses were absent in neutropenic WT-HC mice. SCID-HC mice also showed significantly less leukocyte adherence and emigration than WT-HC mice. Elevated leukocyte adherence and emigration were restored in WT-->SCID mice, despite a continued absence of circulating blood lymphocytes. Selective depletion of either CD4(+) or CD8(+) cell populations attenuated HC-induced leukocyte adhesion but not emigration. However, simultaneous depletion of both CD4(+) and CD8(+) cells attenuated both leukocyte adhesion and emigration to ND levels. DISCUSSION: These findings indicate that both CD4(+) and CD8(+) T-cells contribute to granulocyte adhesion and emigration elicited in postcapillary venules by hypercholesterolemia.

Entities:  

Mesh:

Year:  2002        PMID: 12375178     DOI: 10.1038/sj.mn.7800148

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  6 in total

1.  The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

2.  Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro.

Authors:  G V Chaitanya; S E Franks; W Cromer; S R Wells; M Bienkowska; M H Jennings; A Ruddell; T Ando; Y Wang; Y Gu; M Sapp; J M Mathis; P A Jordan; A Minagar; J S Alexander
Journal:  Lymphat Res Biol       Date:  2010-09       Impact factor: 2.589

3.  Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis.

Authors:  Mutsumi Nagai; Satoshi Terao; Gokhan Yilmaz; Cigdem E Yilmaz; Charles T Esmon; Eiju Watanabe; D Neil Granger
Journal:  Stroke       Date:  2009-11-05       Impact factor: 7.914

4.  CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.

Authors:  Karen Y Stokes; Leshanna Calahan; Candiss M Hamric; Janice M Russell; D Neil Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-26       Impact factor: 4.733

5.  Lymphocyte-derived interferon-gamma mediates ischemia-reperfusion-induced leukocyte and platelet adhesion in intestinal microcirculation.

Authors:  Mohammad Osman; Janice Russell; D Neil Granger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-31       Impact factor: 4.052

6.  Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.

Authors:  F De Salvador-Guillouët; C Sakarovitch; J Durant; K Risso; E Demonchy; P M Roger; E Fontas
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.